phase readout
saveNCT07220954: A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234
ACTIVE_NOT_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Healthy Participants
view source ↗
comments(0)
5-min edit window · permanent after that